Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis
Status:
Completed
Trial end date:
2018-05-07
Target enrollment:
Participant gender:
Summary
This is an exploratory study, which allows analysis of multiple immune parameters derived
from peripheral blood mononuclear cells (PBMCs) from patients with relapsing remitting
multiple sclerosis before and during immune-modulatory treatment with dimethyl fumarate in
comparison to PBMCs from healthy subjects.